NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing percutaneous coronary intervention, adverse event rates are similar with either drug-eluting stents (DESs) or bare metal stents…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing mechanical valve replacement, performing a concomitant Maze procedure during surgery reduces the rate of subsequent thromboembolic events,…
NEW YORK (Reuters Health) – Real-world outcomes among patients with stable coronary disease favor percutaneous coronary intervention over routine medical care alone, according to data maintained by the…
NEW YORK (Reuters Health) – Among patients undergoing invasive coronary angiography or PCI with the use of low-osmolar contrast media (LOCM), adverse outcomes are uncommon with no advantage…
NEW YORK (Reuters Health) – A sirolimus-eluting stent (SES) was superior to a bare-metal stent (BMS) in a group of unselected patients who had primary percutaneous coronary intervention…
NEW YORK (Reuters Health) – For treatment of femoropopliteal artery disease, angioplasty using a paclitaxel-eluting balloon (PEB) is associated with a high sustained patency rate and a low…
NEW YORK (Reuters Health) – Patients with ST-elevation MI undergoing fibrinolysis followed by immediate or late invasive procedures do just as well with unfractionated heparin (UHF) or with…
NEW YORK (Reuters Health) – The need for late target lesion revascularization (TLR) with sirolimus-eluting coronary stents is reduced when patients receive ongoing statin therapy after stent implantation,…
NEW YORK (Reuters Health) – In real-world contemporary clinical practice, the use of the XIENCE V everolimus-eluting coronary stent is associated with lower mortality and reduced stent thrombosis…
NEW YORK (Reuters Health) – During 3 years of follow-up in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS), overall outcomes were significantly better in…